Announcement on Implementation of Semi-annual Dividend Distribution for 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
Filed with SSE · · 4 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-implementation-of-semi-annual-dividend-distribution-for-2025-328
Release
Shanghai Pharmaceuticals Holding Co. Ltd. on 6ix
Earlier from Shanghai Pharmaceuticals
- Indicative Announcement on Restricted Exercise Period for the 3rd Exercise Period of the Reserved Stock Options of 2019 A-share Stock Option Incentive Plan
- Announcement on Obtaining Philippine Drug Registration Certificate for Hydroxychloroquine Sulfate Tablets
- Announcement on the Approval of the Marketing Authorization Application for Sitagliptin Fumarate Tablets (SPH3127 Tablets)
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on Amisulpride Orodispersible Tablets Passing the National Medical Insurance Negotiation and Being Successfully Included in the National Medical Insurance Catalog
Later from Shanghai Pharmaceuticals
- Announcement on Resolutions of the 27th Meeting of the 8th Board of Directors
- Acquisition Report
- Announcement on Independent Exercise Results of Reserved Stock Options in the 3rd Vesting Period of 2019 A-share Stock Option Incentive Plan and in Q4 2025
- Announcement on Obtaining Approval for Production of Pyridostigmine Bromide Oral Solution
- Announcement on Completion of Acquisition of 10% Equity of SIIC Finance Co., Ltd. and Related Party Transactions
Follow Shanghai Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Pharmaceuticals